What Will Investors Harvest From Bayer's Buyout of Monsanto?
In this segment from our MarketFoolery podcast, Mark Reeth and Million Dollar Portfolio ‘s Jason Moser consider whether the merger of the German chemical and pharma giant Bayer (NASDAQOTH: BAYRY) and the U.S. agriculture powerhouse Monsanto (NYSE: MON) is a good deal for shareholders. The two also examine the PR risk factors in taking on… Read More »